Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).
Yao SY, Ng AM, Cass CE, Baldwin SA, Young JD.
???displayArticle.abstract???
The human equilibrative nucleoside transporters hENT1 and hENT2 (each with 456 residues) are 40% identical in amino acid sequence and contain 11 putative transmembrane helices. Both transport purine and pyrimidine nucleosides and are distinguished functionally by a difference in sensitivity to inhibition by nanomolar concentrations of nitrobenzylmercaptopurine ribonucleoside (NBMPR), hENT1 being NBMPR-sensitive. Previously, we used heterologous expression in Xenopus oocytes to demonstrate that recombinant hENT2 and its rat ortholog rENT2 also transport purine and pyrimidine bases, h/rENT2 representing the first identified mammalian nucleobase transporter proteins (Yao, S. Y., Ng, A. M., Vickers, M. F., Sundaram, M., Cass, C. E., Baldwin, S. A., and Young, J. D. (2002) J. Biol. Chem. 277, 24938-24948). The same study also revealed lower, but significant, transport of hypoxanthine by h/rENT1. In the present investigation, we have used the enhanced Xenopus oocyte expression vector pGEMHE to demonstrate that hENT1 additionally transports thymine and adenine and, to a lesser extent, uracil and guanine. Fluxes of hypoxanthine, thymine, and adenine by hENT1 were saturable and inhibited by NBMPR. Ratios of V(max) (pmol/oocyte · min(-1)):K(m) (mm), a measure of transport efficiency, were 86, 177, and 120 for hypoxantine, thymine, and adenine, respectively, compared with 265 for uridine. Hypoxanthine influx was competitively inhibited by uridine, indicating common or overlapping nucleobase and nucleoside permeant binding pockets, and the anticancer nucleobase drugs 5-fluorouracil and 6-mercaptopurine were also transported. Nucleobase transport activity was absent from an engineered cysteine-less version hENT1 (hENT1C-) in which all 10 endogenous cysteine residues were mutated to serine. Site-directed mutagenesis identified Cys-414 in transmembrane helix 10 of hENT1 as the residue conferring nucleobase transport activity to the wild-type transporter.
Abramson,
Structure and mechanism of the lactose permease of Escherichia coli.
2003, Pubmed
Abramson,
Structure and mechanism of the lactose permease of Escherichia coli.
2003,
Pubmed Arastu-Kapur,
Second-site suppression of a nonfunctional mutation within the Leishmania donovani inosine-guanosine transporter.
2005,
Pubmed Aronow,
Role of the nucleoside transport function in the transport and salvage of purine nucleobases.
1986,
Pubmed Baldwin,
The equilibrative nucleoside transporter family, SLC29.
2004,
Pubmed Baldwin,
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes.
2005,
Pubmed
,
Xenbase Baldwin,
Nucleoside transport as a potential target for chemotherapy in malaria.
2007,
Pubmed Barnes,
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.
2006,
Pubmed
,
Xenbase Barros,
Hypoxanthine transport in the guinea pig and human placenta is a carrier-mediated process that does not involve nucleoside transporters.
1994,
Pubmed Belt,
Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Differences in sensitivity to nitrobenzylthioinosine and thiol reagents.
1985,
Pubmed Cabrita,
Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes.
2002,
Pubmed Caulfield,
SLC2A9 is a high-capacity urate transporter in humans.
2008,
Pubmed
,
Xenbase Crawford,
Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
1998,
Pubmed de Koning,
Nucleobase transporters (review).
2000,
Pubmed Engel,
Identification and characterization of a novel monoamine transporter in the human brain.
2004,
Pubmed
,
Xenbase Gati,
Nucleobase transporter-mediated permeation of 2',3'-dideoxyguanosine in human erythrocytes and human T-lymphoblastoid CCRF-CEM cells.
1992,
Pubmed Govindarajan,
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.
2009,
Pubmed
,
Xenbase Gray,
The concentrative nucleoside transporter family, SLC28.
2004,
Pubmed Griffith,
Nucleoside and nucleobase transport systems of mammalian cells.
1996,
Pubmed Griffith,
Characterization of a sodium-dependent concentrative nucleobase-transport system in guinea-pig kidney cortex brush-border membrane vesicles.
1994,
Pubmed Griffith,
High affinity sodium-dependent nucleobase transport in cultured renal epithelial cells (LLC-PK1).
1993,
Pubmed Griffith,
Nucleoside transport in cultured LLC-PK1 epithelia.
1992,
Pubmed Griffiths,
Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs.
1997,
Pubmed
,
Xenbase Griffiths,
Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
1997,
Pubmed
,
Xenbase Hoque,
A purine-selective nucleobase/nucleoside transporter in PK15NTD cells.
2008,
Pubmed Huang,
Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli.
2003,
Pubmed Kato,
Characterization of nucleobase transport by mouse Sertoli cell line TM4.
2009,
Pubmed Kato,
Characterization of novel Na+-dependent nucleobase transport systems at the blood-testis barrier.
2006,
Pubmed King,
Nucleoside transporters: from scavengers to novel therapeutic targets.
2006,
Pubmed Landfear,
Nucleoside and nucleobase transporters in parasitic protozoa.
2004,
Pubmed Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase Liu,
Switching between the two action modes of the dual-affinity nitrate transporter CHL1 by phosphorylation.
2003,
Pubmed
,
Xenbase Nagai,
Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2.
2007,
Pubmed Newstead,
Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.
2011,
Pubmed Pantazopoulou,
Fungal nucleobase transporters.
2007,
Pubmed Papageorgiou,
Kinetic and mutational analysis of the Trypanosoma brucei NBT1 nucleobase transporter expressed in Saccharomyces cerevisiae reveals structural similarities between ENT and MFS transporters.
2008,
Pubmed Parker,
Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.
2000,
Pubmed
,
Xenbase Parkinson,
Molecular biology of nucleoside transporters and their distributions and functions in the brain.
2011,
Pubmed
,
Xenbase Plagemann,
Nucleoside and nucleobase transport in animal cells.
1988,
Pubmed Ritzel,
Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
2001,
Pubmed
,
Xenbase Ritzel,
Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.
1998,
Pubmed
,
Xenbase Shayeghi,
Nucleobase transport in opossum kidney epithelial cells and Xenopus laevis oocytes: the characterisation, structure-activity relationship of uracil analogues and oocyte expression studies of sodium-dependent and -independent hypoxanthine uptake.
1999,
Pubmed
,
Xenbase Smith,
Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.
2004,
Pubmed
,
Xenbase Sundaram,
Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.
2001,
Pubmed
,
Xenbase Ullman,
Expression of the high-affinity purine nucleobase transporter in mutant mouse S49 cells does not require a functional wild-type nucleoside-nucleobase transporter.
1987,
Pubmed Valdés,
An ab Initio structural model of a nucleoside permease predicts functionally important residues.
2009,
Pubmed Ward,
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
2000,
Pubmed Washington,
Mechanisms of nucleobase transport in rabbit choroid plexus. Evidence for a Na(+)-dependent nucleobase transporter with broad substrate selectivity.
1995,
Pubmed Yamamoto,
Identification and functional characterization of the first nucleobase transporter in mammals: implication in the species difference in the intestinal absorption mechanism of nucleobases and their analogs between higher primates and other mammals.
2010,
Pubmed Yao,
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
1997,
Pubmed
,
Xenbase Yao,
Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation.
2002,
Pubmed
,
Xenbase Yao,
Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2.
2001,
Pubmed
,
Xenbase Young,
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.
2008,
Pubmed Zhang,
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.
2007,
Pubmed
